Search research articles
Contact Us
Filters
Showing results (71-80 of 104) with videos related to
Page
of 11
Sort By:
Journal of Endocrinological Investigation
|
December 17, 1998
A thyrotropin-secreting pituitary adenoma as a cause of thyrotoxic periodic paralysis
A M Alings, E Fliers, W W de Herder, et al.
The Netherlands Journal of Medicine
|
June 28, 2017
Transient thyrotoxicosis during nivolumab treatment
M J van Kooten, G van den Berg, A W J M Glaudemans, et al.
Frontiers in Endocrinology
|
November 8, 2021
Focal Thyroid Incidentalomas on <sup>18</sup>F-FDG PET/CT: A Systematic Review and Meta-Analysis on Prevalence, Risk of Malignancy and Inconclusive Fine Needle Aspiration
J F de Leijer, M J H Metman, A van der Hoorn, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 21, 2007
A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma
J W B de Groot, B A Zonnenberg, P Quarles van Ufford-Mannesse, et al.
World Journal of Surgery
|
October 27, 2022
Thyroid Lobectomy for Low-Risk 1-4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-Up
J F Lin, P M Rodriguez Schaap, M J H Metman, et al.
European Journal of Endocrinology
|
January 10, 2015
Therapy of endocrine disease: response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysis
E N Klein Hesselink, D Steenvoorden, E Kapiteijn, et al.
European Journal of Endocrinology
|
May 30, 2003
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
K M van Tol, P L Jager, E G E de Vries, et al.
Clinical Endocrinology
|
November 3, 2010
The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial ¹³¹I therapy
D van Dijk, J T M Plukker, A N A van der Horst-Schrivers, et al.
The Netherlands Journal of Medicine
|
January 8, 2014
Intestinal pseudo-obstruction as a complication of paragangliomas: case report and literature review
T E Osinga, M N Kerstens, M M van der Klauw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2009
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors
S F Oosting, E C de Haas, T P Links, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 104) with videos related to
Sort By:
Page
of 11
Journal of Endocrinological Investigation
|
December 17, 1998
A thyrotropin-secreting pituitary adenoma as a cause of thyrotoxic periodic paralysis
A M Alings, E Fliers, W W de Herder, et al.
The Netherlands Journal of Medicine
|
June 28, 2017
Transient thyrotoxicosis during nivolumab treatment
M J van Kooten, G van den Berg, A W J M Glaudemans, et al.
Frontiers in Endocrinology
|
November 8, 2021
Focal Thyroid Incidentalomas on <sup>18</sup>F-FDG PET/CT: A Systematic Review and Meta-Analysis on Prevalence, Risk of Malignancy and Inconclusive Fine Needle Aspiration
J F de Leijer, M J H Metman, A van der Hoorn, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 21, 2007
A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma
J W B de Groot, B A Zonnenberg, P Quarles van Ufford-Mannesse, et al.
World Journal of Surgery
|
October 27, 2022
Thyroid Lobectomy for Low-Risk 1-4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-Up
J F Lin, P M Rodriguez Schaap, M J H Metman, et al.
European Journal of Endocrinology
|
January 10, 2015
Therapy of endocrine disease: response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysis
E N Klein Hesselink, D Steenvoorden, E Kapiteijn, et al.
European Journal of Endocrinology
|
May 30, 2003
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
K M van Tol, P L Jager, E G E de Vries, et al.
Clinical Endocrinology
|
November 3, 2010
The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial ¹³¹I therapy
D van Dijk, J T M Plukker, A N A van der Horst-Schrivers, et al.
The Netherlands Journal of Medicine
|
January 8, 2014
Intestinal pseudo-obstruction as a complication of paragangliomas: case report and literature review
T E Osinga, M N Kerstens, M M van der Klauw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2009
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors
S F Oosting, E C de Haas, T P Links, et al.
Page
of 11